7/19/2007

Advisers to the European Medicines Agency recommended approval of GlaxoSmithKline's cervical cancer vaccine Cervarix. The vaccine, not yet approved in the U.S., would compete with Merck's Gardasil. Both protect against human papillomavirus.

Related Summaries